Related Experiment Videos
Glomerulonephritis induced in sheep by immunization with human glomerular basement membrane
Kidney International
|January 1, 1987
Summary
Researchers compared antibodies in sheep nephritis and human Goodpasture's syndrome. They found the M2 subunit of collagen IV is a key target antigen in both anti-glomerular basement membrane diseases.
Area of Science:
- Immunology
- Nephrology
- Molecular Biology
Background:
- Anti-glomerular basement membrane (GBM) nephritis, including Goodpasture's syndrome, involves autoantibodies targeting the GBM.
- Understanding the specific antigens targeted by these antibodies is crucial for diagnosing and treating anti-GBM diseases.
Purpose of the Study:
- To investigate and compare the specificity of antibodies in experimental nephritis in sheep (Steblay's nephritis) with those in human anti-GBM nephritis (Goodpasture's syndrome).
- To identify the specific GBM antigens recognized by autoantibodies in both conditions.
Main Methods:
- Sheep were immunized with human GBM, and antibody reactivities were measured using ELISA.
- Antibodies eluted from kidneys of nephritic sheep were analyzed by immunoblotting and ELISA.
- Comparison of antibody specificities between experimental and human nephritis models.
Main Results:
- Sheep developed high titers of antibodies against human GBM antigens.
- Antibodies against sheep GBM increased with nephritis development and localized to kidneys.
- Eluted antibodies primarily recognized the M2 subunit of the globular domain of collagen IV.
- This M2 subunit is also the major antigen targeted in human Goodpasture's syndrome.
Conclusions:
- The M2 subunit of the globular domain of collagen IV is a primary nephritogen in both Steblay's nephritis and Goodpasture's syndrome.
- This finding highlights a conserved autoimmune target across species for anti-GBM diseases.
- The M2 subunit represents a key antigen for understanding and potentially treating anti-GBM antibody diseases.